Walking Dead Macrophage-Based Positive Enhancement MRI for Ultrahighly Efficient Diagnosis of Nephritis

Nephritis is an inflammatory condition of the glomerulus, and the clinical gold standard for its diagnosis is a kidney biopsy. However, obtaining biopsy results can take several days, which does not meet the requirement of rapid diagnosis, especially for rapidly progressive types. To achieve an effective and noninvasive diagnosis, we propose a nephritis-specific, positive magnetic resonance imaging (MRI) contrast agent based on Gd3+ anchored walking dead macrophage Gd-RAW. Gd-RAW exhibits high selectivity for inflammatory renal parenchyma and provides comparable results to histopathology methods. The Gd-RAW-based MRI contrast agent reduces the diagnostic time of nephritis from 14 days of biopsy to 1 h. Furthermore, in a unilateral nephritis model constructed by increasing the glycerol concentration, the T1WI of renal parenchyma exhibits an increased signal-to-noise ratio, which is crucial for evaluating nephritic severity. This work promotes rapid diagnosis of nephritis and potentially provides sufficient evidence for clinicians to offer timely treatment to patients. The methodology of paramagnetic ion-anchored macrophage corpse also opens up new prospects for designing more specific and biosafe MRI contrast agents.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:96

Enthalten in:

Analytical chemistry - 96(2024), 12 vom: 26. März, Seite 4933-4941

Sprache:

Englisch

Beteiligte Personen:

Lin, Peiru [VerfasserIn]
Wu, Wanjia [VerfasserIn]
Chen, Chuyao [VerfasserIn]
Chen, Yuying [VerfasserIn]
Ouyang, Sixue [VerfasserIn]
Song, Zibin [VerfasserIn]
Xia, Yubin [VerfasserIn]
An, Yida [VerfasserIn]
Zhang, Nan [VerfasserIn]
Zhao, Peng [VerfasserIn]
Lin, Bingquan [VerfasserIn]
Tao, Jia [VerfasserIn]

Links:

Volltext

Themen:

Contrast Media
Journal Article

Anmerkungen:

Date Completed 27.03.2024

Date Revised 27.03.2024

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1021/acs.analchem.3c05777

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM369729536